AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$630M |
| 2 |
Visa
V
|
+$363M |
| 3 |
MSCI
MSCI
|
+$322M |
| 4 |
Walt Disney
DIS
|
+$297M |
| 5 |
Monster Beverage
MNST
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$584M |
| 2 |
Nike
NKE
|
+$573M |
| 3 |
Meta Platforms (Facebook)
META
|
+$489M |
| 4 |
Adobe
ADBE
|
+$418M |
| 5 |
Advanced Micro Devices
AMD
|
+$416M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.76% |
| 2 | Healthcare | 17.68% |
| 3 | Financials | 13.09% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.07B
| $346K | ﹤0.01% |
+3,935
| New | +$367K |
|
|
NVMI
2802
Nova
NVMI
$12.4B
| $346K | ﹤0.01% |
+4,060
| New | +$399K |
|
2803
Alamos Gold
AGI
$11.6B
| $345K | ﹤0.01% |
46,519
+27,300
| +142% | +$202K |
|
2804
Community Health Systems
CYH
$393M
| $345K | ﹤0.01% |
160,420
-180,427
| -53% | -$598K |
|
2805
Ocugen
OCGN
$416M
| $344K | ﹤0.01% |
193,200
| – | – |
|
2806
Rackspace Technology
RXT
$1.05B
| $344K | ﹤0.01% |
84,286
-221
| -0.3% | -$1.28K |
|
|
POSH
2807
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $343K | ﹤0.01% |
21,900
+8,800
| +67% | +$105K |
|
2808
Cullinan Oncology
CGEM
$1.01B
| $342K | ﹤0.01% |
26,700
+2,400
| +10% | +$32.3K |
|
|
AZRE
2809
DELISTED
Azure Power Global Limited
AZRE
| $341K | ﹤0.01% |
61,584
+4,970
| +9% | +$45.8K |
|
|
ICPT
2810
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $340K | ﹤0.01% |
24,370
| – | – |
|
2811
Northrim BanCorp
NRIM
$590M
| $339K | ﹤0.01% |
+32,660
| New | +$335K |
|
2812
Arcturus Therapeutics
ARCT
$164M
| $338K | ﹤0.01% |
22,800
-3,300
| -13% | -$55.4K |
|
2813
Precigen
PGEN
$2.24B
| $338K | ﹤0.01% |
159,500
+25,500
| +19% | +$53.8K |
|
2814
Merchants Bancorp
MBIN
$2.53B
| $337K | ﹤0.01% |
14,600
+3,000
| +26% | +$76.8K |
|
2815
Protagonist Therapeutics
PTGX
$8.79B
| $337K | ﹤0.01% |
40,000
-6,000
| -13% | -$56.8K |
|
2816
Ecovyst
ECVT
$1.32B
| $336K | ﹤0.01% |
39,800
+13,400
| +51% | +$127K |
|
2817
Phibro Animal Health
PAHC
$1.47B
| $335K | ﹤0.01% |
25,233
-9,962
| -28% | -$172K |
|
2818
American Vanguard Corp
AVD
$68.4M
| $334K | ﹤0.01% |
17,857
+496
| +3% | +$10.3K |
|
2819
IDEAYA Biosciences
IDYA
$3.42B
| $334K | ﹤0.01% |
22,400
| – | – |
|
2820
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.7B
| $334K | ﹤0.01% |
5,306
+345
| +7% | +$23.8K |
|
2821
MiMedx Group
MDXG
$602M
| $333K | ﹤0.01% |
116,200
| – | – |
|
|
CLDT
2822
Chatham Lodging
CLDT
$622M
| $330K | ﹤0.01% |
33,444
-3,500
| -9% | -$42.1K |
|
2823
MacroGenics
MGNX
$235M
| $328K | ﹤0.01% |
94,900
-8,500
| -8% | -$32.5K |
|
|
ALX
2824
Alexander's
ALX
$1.3B
| $327K | ﹤0.01% |
1,563
+202
| +15% | +$47.7K |
|
2825
Boston Omaha
BOC
$428M
| $325K | ﹤0.01% |
14,100
| – | – |
|
Similar funds
AllianceBernstein's Q3 2022 Portfolio in Review
As of Q3 2022, AllianceBernstein held 3,359 positions worth $207B, down 5.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AllianceBernstein's Q3 2022 filing shows 102 new, 1,361 increased, 1,417 reduced and 89 closed positions. Its largest new stake was Genmab: 5,779,489 shares worth $186M. The largest sale was Qualcomm, an estimated $584M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q3 2022 buy was Genmab: 5,779,489 shares worth $186M.
- AllianceBernstein added most to iShares Russell 1000 Growth ETF in Q3 2022, an estimated $630M increase.
- AllianceBernstein's biggest Q3 2022 reduction was Qualcomm, cutting an estimated $584M.
- AllianceBernstein fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $244M.
- AllianceBernstein's ten largest holdings make up 23% of its $207B portfolio in Q3 2022.
- AllianceBernstein opened 102 new positions and closed 89 in Q3 2022.
- AllianceBernstein's portfolio value fell 5.7% quarter-over-quarter to $207B.
Based on AllianceBernstein's 13F filing for Q3 2022, filed 15 Nov 2022.